Browsing Tag
aTyr Pharma
1 post
Efzofitimod returns to pivotal development as aTyr Pharma targets narrower sarcoidosis population
aTyr Pharma gains FDA alignment for a redesigned efzofitimod Phase 3 trial, but financing and clinical validation remain major hurdles.